Related Experiment Video

Updated: Aug 8, 2026

Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 25, 2010

Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological

H L Kim1, D J Vander Griend, X Yang

  • 1Department of Surgery, The University of Chicago, Illinois 60637, USA.

Cancer Research
|April 18, 2001
PubMed

Insights

Mitogen-activated protein kinase kinase 4 (MKK4) suppresses prostate cancer metastasis. MKK4 is frequently down-regulated in clinical prostate cancer, indicating its role in disease progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Mitogen-activated protein kinase kinase 4 (MKK4) has demonstrated efficacy in suppressing prostate cancer metastasis in vivo.
  • Dysregulation of the MKK4 signaling pathway is implicated in various cancers.

Purpose of the Study:

  • To investigate the role of MKK4 dysregulation in the development and progression of clinical prostate cancer.
  • To determine if MKK4 protein levels correlate with tumor grade and if allelic loss contributes to its down-regulation.

Main Methods:

  • Immunohistochemical analysis of MKK4 expression in normal and cancerous prostate tissues.
  • Correlation analysis between MKK4 expression levels and Gleason patterns.
  • Loss of heterozygosity (LOH) analysis at the MKK4 locus (D17S969) in metastatic prostate cancer lesions.

Main Results:

  • MKK4 expression is high in normal prostate epithelium but significantly down-regulated in neoplastic tissues.
  • A direct, inverse relationship exists between Gleason pattern and MKK4 expression, indicating reduced MKK4 in higher-grade tumors.
  • 31% of metastatic prostate cancer lesions exhibited MKK4 loss of heterozygosity, without frequent coding region mutations in the remaining allele.

Conclusions:

  • MKK4 protein is consistently down-regulated during prostate cancer progression.
  • Dysregulation of the MKK4 signaling cascade plays a role in clinical prostate cancer.
  • Allelic loss is a contributing factor to MKK4 down-regulation in prostate cancer development.

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 19, 2013

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...